High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

American Journal of Gastroenterology

Volumn 96, Issue 5, 2001, Pages 1558-1562

  Harnois, Denise M ^a   Angulo, Paul ^a   Jorgensen, Roberta A ^a   Larusso, Nicholas F ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; PLACEBO; URSODEOXYCHOLIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; SURVIVAL;

EID: 0034998596     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02340-1     Document Type: Article

References (19)

1. Angulo P., Lindor K.D. Primary sclerosing cholangitis. Hepatology. 30:1999;325-332.
2. Porayko M.K., Wiesner R.H., LaRusso N.F., et al. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology. 98:1990;1594-1602.
3. Angulo P., Lindor K.D. Primary sclerosing cholangitis Emerging new promising therapies . J Clin Gastroenterol. 31:2000;271-273.
4. Calmus Y., Gane P., Rouger P., et al. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis Effect of ursodeoxycholic acid . Hepatology. 11:1990;12-15.
5. Rodrigues C.M.P., Fan G., Wong P.Y., et al. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med. 4:1998;165-178.
6. Beuer U., Boyer J.L., Paumgartner G. Ursodeoxycholic acid in cholestasis Potential mechanisms of action and therapeutic applications . Hepatology. 28:1998;1449-1453.
7. Lindor K.D. Ursodiol for primary sclerosing cholangitis. N Engl J Med. 336:1997;691-695.
8. O'Brien C.B., Senior J.R., Arora-Mirchandani R., et al. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis A 30-month pilot study . Hepatology. 14:1991;838-847.
9. Beuchers U., Spengler U., Kruis W., et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis A placebo-controlled trial . Hepatology. 16:1992;707-714.
10. Stiehl A., Walker S., Stiehl L., et al. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol. 20:1994;57-64.
11. Poupon R.E., Cauch-Dudek K., Lindor K.D., et al. Gastroenterology. 113:1997;884-890.
12. Kim W.R., Poterucha J.J., Wiesner R.H., et al. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology. 29:1999;1643-1648.
13. Mitchell S.A., Bansi D., Hunt N., et al. High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC) Results after two years of a randomized, double-blind, placebo-controlled trial . Gastroenterology. 112:1997;A1335 (abstract).
14. Van Thiel D.H., Carroll P., Abu-Elmagd K., et al. Tacrolimus (FK506), a treatment for primary sclerosing cholangitis. Results of an open-label preliminary trial. Am J Gastroenterol. 90:1995;445-449.
15. Schramm C., Schirmacher P., Helmreich-Becker I., et al. Combined therapy with azathioprine, prednisone and ursodiol in patients with primary sclerosing cholangitis. A case series. Ann Intern Med. 131:1999;943-946.
16. Angulo P., Lindor K.D. Medical treatment for primary sclerosing cholangitis Risk versus benefit . Hepatology. 32:2000;871-872.
17. Colombo C., Setchell K.D., Podda M., et al. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr. 117:1990;482-489.
18. Colombo C., Crosignani A., Assaisso M., et al. Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease A dose-response study . Hepatology. 16:1992;924-930.
19. Angulo P., Dickson E.R., Therneau T.M., et al. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis A randomized trial . J Hepatol. 30:1999;830-835.